Anti-Disinformation Messaging for Menthol Cigarette Addiction

Overseen By Study Coordinator

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Rutgers, The State University of New Jersey

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 4

What You Need to Know Before You Apply

What is the purpose of this trial?

Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.

Who Is on the Research Team?

Andrea C Villanti, PhD, MPH

Principal Investigator

Rutgers University

Kymberle L Sterling, DrPH

Principal Investigator

Rutgers University

Are You a Good Fit for This Trial?

Inclusion Criteria

Willing to engage in all online study activities including online quarterly surveys over a 12-month period.

African American or Black adults

I am 18 years old or older.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Survey

Participants complete the baseline survey providing sociodemographic information and baseline measures of study outcomes

1 week

Intervention

Participants receive the ADM intervention or control condition, with follow-up assessments at 3, 6, 9, and 12 months

12 months

4 follow-up assessments (3, 6, 9, 12 months)

Community-level Intervention

Community partners in Atlanta disseminate ADM intervention messages through community networks for 12 months

12 months

Follow-up

Participants are monitored for changes in beliefs and knowledge about tobacco industry and policies

12 months

What Are the Treatments Tested in This Trial?

Interventions

• Anti-disinformation Messaging

How Is the Trial Designed?

Group I: Individual-level intervention + Community-level intervention Experimental Treatment 2 Interventions

Group II: Individual-level intervention + Community-level control Experimental Treatment 1 Intervention

Group III: Individual-level control + Community-level intervention Experimental Treatment 1 Intervention

Group IV: Individual-level control + Community-level control Active Control 1 Intervention

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials

471

Recruited

81,700+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials

473

Recruited

1,374,000+